Results 141 to 150 of about 35,947 (209)

Comparison of the Effects and Safety of Planned Limited-Time Withdrawal Versus Continuous Maintenance of Interleukin Inhibitors in Patients with Psoriasis: A Systematic Review and Network Meta-Analysis. [PDF]

Dermatol Ther (Heidelb)
de Sena RR, de C Mesquita K, Barroso LF, Canabrava PBE, Zanghelini F, Gomes CM.   +5 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Tapinarof 1% Cream in Psoriasis: An Observational Study From Bangladesh. [PDF]

Cureus
Huq S, Noor T, Hena Chowdhury A, Abdul Latif Khan M, Nahar Asma A, Malabeka S, Tasmin Tahnin NA, Rahman Mahin T, Al Mamun S, Jesmin A.   +9 more
europepmc   +1 more source

Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre study. [PDF]

RMD Open
Paci V, Zabotti A, Fontanarosa A, Celletti E, Lopalco G, Foti R, Di Zio R, Perrotta FM, Di Penta M, Visalli E, Agostinelli A, Marchionni G, Ramonda R, Foti R, Iannone F, Quartuccio L, Gesuita R, Moroncini G, Luchetti Gentiloni MM, Lubrano E.   +19 more
europepmc   +1 more source

Safety and efficacy of oral icotrokinra for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
AlJuma RS, Hashim S, Alshamali MA, Alkhatlan S, Hammadi DJ, Alharran AM.   +5 more
europepmc   +1 more source

Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients. [PDF]

Am J Clin Dermatol, 2017
Hägg D, Sundström A, Eriksson M, Schmitt-Egenolf M.   +3 more
europepmc   +1 more source

The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. [PDF]

Dermatol Ther (Heidelb)
Alexis A, McMichael A, Vashi N, Bhutani T, Yeung J, Alkousakis T, Rowland K, Choi O, Ma T, Chan D, Lester J, Rodriguez AO, Yadav G, Kindred C, Grimes P, Taylor SC, Desai SR.   +16 more
europepmc   +1 more source

Depression, Anxiety and Quality of Life in Patients with Atopic Dermatitis and Psoriasis. [PDF]

Medicina (Kaunas)
Arnīte A, Bondare-Ansberga V, Reinberga L, Hartmane I, Mikažāns I.   +4 more
europepmc   +1 more source

Perspectives and Real-World Clinical Practice of Portuguese Dermatologists on Biologic Dose Spacing in Psoriasis: Results from a Nationwide Survey. [PDF]

Dermatol Ther (Heidelb)
Ferreira C, Torres T.
europepmc   +1 more source

Predictive Factors of Early Super-Response to Biologic Agents in Psoriasis: Insights from Real-World Evidence. [PDF]

Clin Cosmet Investig Dermatol
Koç Yıldırım S, Ayyıldız SM, Demirel Öğüt N, Erbağcı E, Ünal S, Gokyayla E.   +5 more
europepmc   +1 more source

The Impact of Tobacco Smoking on Treatment Response Among Patients With Psoriasis Undergoing Biologic Treatment: Prospective Observational Study.

JMIR Hum Factors
Shen F, Ding Y, Zhang X, Xu Q, Duan Z, Cai R, Zhang R, Gao X, Wang R.   +8 more
europepmc   +1 more source